According to a longitudinal study published in the Journal of the American Medical Association, depression relapse may be triggered by a patient's initial major depressive disorder (MDD) experience that causes morphologic changes in brain regions responsible for regulating emotions and cognitive control.

After 14 years as CEO of the Association for Medical Imaging Management (AHRA), Ed Cronin has announced he will retire at the end of 2018.

A novel machine learning model could accurately predict which men might benefit most from additional imaging before a prostate biopsy, saving patients both money and discomfort, a new study states.

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

DBT screenings have higher cancer-detection rates, fewer false positives than 2D mammography

Easing clinician burden under the payment tracks implemented as part of the Medicare Access and CHIP Reauthorization Act (MACRA) will be a priority for CMS in this year’s rulemaking, according to Kate Goodrich, MD, the agency’s chief medical officer. What won’t be changing, however, is requiring providers to meet the 2015 edition of certified electronic health record technology (CHERT) standards.

Lawrence Carl, MD, is the medical director for Main Street Radiology (MSR) in Queens, N.Y., a board-certified radiologist and assistant radiology professor at Weill Cornell. His medical director responsibilities include keeping an eye out for emerging technologies to positively impact workflow and patient care in outpatient radiology. To that end, Dr. Carl leads MSR administration and technology professionals to multiple educational events each year.

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.